Neumora Therapeutics releases corporate presentation at Guggenheim summit; no material details disclosed

Neumora Therapeutics, Inc.

Presentation dated February 2026 made available for Guggenheim Emerging Outlook: Biotech Summit.
No financial results, pipeline updates, or guidance changes were provided in the filing.
The filing is a routine Regulation FD disclosure with limited substantive news.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.